Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_assertion type Assertion NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_head.
- NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_assertion wasGeneratedBy ECO_0000203 NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_provenance.
- NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_assertion wasDerivedFrom befree-20150227 NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_provenance.
- NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_assertion SIO_000772 16435073 NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_provenance.
- NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_assertion evidence source_evidence_literature NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_provenance.
- NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_assertion description "[Further analysis of primary tumors indicated that the frequency of hypermethylation was high for ASC (82%) and PAX3 (86%) in all tumor types, and high for RIPK3 in small cell carcinoma (57%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893392.RALZPWR3fUfEqpcSQvMn5Vim7RgzL6NYL9bVa2UlWzSaA130_provenance.